医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

KILL CANbridge Modernizes with Veeva Vault QualityDocs to Support Global Compliance for Clinical Trials

2020年10月15日 PM02:53
このエントリーをはてなブックマークに追加


 

Veeva Systems Inc. requests that their press release NewsItemId: 20201014006039 issued October 14, 2020 “CANbridge Modernizes with Veeva Vault QualityDocs to Support Global Compliance for Clinical Trials” be killed.

The release was issued in error by Veeva Systems Inc.

A replacement release will not be issued.

CONTACT

Brittagh Lynn

Veeva Systems

+61 435 922 069

brittagh.lynn@contractor.veeva.com

Bec Sands

Polkadot Communications

+61 416 119 858

bec@polkadotcomms.com.au

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  •  Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
  • ENHERTU® Reduced the Risk of Disease Progression or Death by 72% Versus Trastuzumab Emtansine (T-DM1) in Patients with HER2 Positive Metastatic Breast Cancer
  • ENHERTU® Demonstrated Clinically Meaningful and Durable Response in Patients with HER2 Positive Advanced Gastric Cancer in DESTINY-Gastric02 Phase 2 Trial
  • 武田的EXKIVITY™ (mobocertinib)成为美国FDA首次核准的专为EGFR外显子20插入+ NSCLC患者设计的口服治疗药物
  • Masimo上市单例患者使用的rainbow® SuperSensor™